1.Abdel-Ghafar, AN, et al. Update on avian influenza A (H5N1) virus infection in humans. New England Journal of Medicine 2008; 358: 261–273.
2.Oner, AF, et al. Avian influenza A (H5N1) infection in eastern Turkey in 2006. New England Journal of Medicine 2006; 355: 2179–2185.
4.Centers for Disease Control and Prevention. Update: infections with a swine-origin influenza A (H1N1) virus – United States and other countries, 28 April 2009. Morbidity and Mortality Weekly Report 2009; 58: 431–433.
5.Liem, NT, Lim, W. Lack of H5N1 avian influenza transmission to hospital employees, Hanoi, 2004. Emerging Infectious Diseases 2005; 11: 210–215.
6.Gambotto, A, et al. Human infection with highly pathogenic H5N1 influenza virus. Lancet 2008; 371: 1464–1475.
7.Yang, Y, et al. Detecting human-to-human transmission of avian influenza A (H5N1). Emerging Infectious Diseases 2007; 13: 1348–1353.
8.Nicholls, JM, et al. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nature Medicine 2007; 13: 147–149.
9.Yen, HL, et al. Inefficient transmission of H5N1 influenza viruses in a ferret contact model. Journal of Virology 2007; 81: 6890–6898.
10.Altiok, E, et al. Mutations in influenza A virus (H5N1) and possible limited spread, Turkey, 2006. Emerging Infectious Diseases 2008; 14: 491–492.
11.Palmer, DF, et al. Advanced Laboratory Techniques for Influenza Diagnosis. Welfare Immunology Series 6. Atlanta: U.S. Dept. of Health, Education, and Welfare, 1975.
12.Centers for Disease Control and Prevention. Concepts and procedures for laboratory based influenza surveillance. Washington, DC: U.S. Dept. of Health and Human Services, 1982.
13.Reed, LJ, Muench, H. A simple method of estimating fifty percent endpoints. American Journal of Hygiene 1938; 27: 493–497.
14.Kohler, G, Milstein, C. Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. European Journal of Immunology 1976; 6: 511–519.
15.Russell, PH, Alexander, DJ. Antigenic variation of Newcastle disease virus strains detected by monoclonal antibodies. Archives of Virology 1983; 75: 243–253.
16.Puzelli, S, et al. Serological analysis of serum samples from humans exposed to avian H7 influenza viruses in Italy between 1999 and 2003. Journal of Infectious Diseases 2005; 192: 1318–1322.
17.Ortiz, JR, et al. Lack of evidence of avian-to-human transmission of avian influenza A (H5N1) virus among poultry workers, Kano, Nigeria, 2006. Journal of Infectious Diseases 2007; 196: 1685–1691.
18.Rowe, T, et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. Journal of Clinical Microbiology 1999; 37: 937–943.
19.Katz, JM, et al. Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. Journal of Infectious Diseases 1999; 180: 1763–1770.
20.Frank, AL, et al. Microneutralization test for influenza A and B and parainfluenza 1 and 2 viruses that uses continuous cell lines and fresh serum enhancement. Journal of Clinical Microbiology 1980; 12: 426–432.
21.Kayali, G, et al. Testing human sera for antibodies against avian influenza viruses: horse RBC hemagglutination inhibition vs. microneutralization assays. Journal of Clinical Virology 2008; 43: 73–78.